Banque Cantonale Vaudoise Novo Cure LTD Transaction History

Banque Cantonale Vaudoise

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 29, 2021	SELL	$116.17 - $194.55 $441,446 - $739,290	-3,800 Reduced 60.32%	2,500 $290,000
Q2 2021 Aug 11, 2021	SELL	$130.4 - $225.58 $13,040 - $22,558	-100 Reduced 1.56%	6,300 $1.4 Million
Q1 2021 May 11, 2021	BUY	$124.11 - $190.17 $576,863 - $883,910	4,648 Added 265.3%	6,400 $847,000
Q4 2020 Feb 05, 2021	BUY	$112.16 - $174.14 $1,009 - $1,567	9 Added 0.52%	1,752 $303,000
Q3 2020 Oct 30, 2020	SELL	$58.05 - $111.31 $4,179 - $8,014	-72 Reduced 3.97%	1,743 $194,000
Q2 2020 Jul 22, 2020	SELL	$57.2 - $74.41 $40,383 - $52,533	-706 Reduced 28.0%	1,815 $108,000
Q1 2020 May 14, 2020	SELL	$57.05 - $95.75 $9,983 - $16,756	-175 Reduced 6.49%	2,521 $170,000
Q4 2019 Feb 10, 2020	BUY	$68.3 - $93.8 $184,136 - $252,884	2,696 New	2,696 $227,000

294

75.8M

1.77M

538K

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.64B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.